Stock screener
Filter every US stock on the same numbers behind our pages, from P/E to insider buying. Or start from one of the ready-made ideas.
Filter every US stock on the same numbers behind our pages, from P/E to insider buying. Or start from one of the ready-made ideas.
Prices and filings as of the close on Oct 30, 2026
| # | Company | Share price | 1D | Market cap | Short % shares | Days to cover | Score | P/E | Margin of safety | Rev. growth | Net margin | Yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 151 | $13.83 | −0.79% | $3.0B | 15.7% | 8.3 | 2 | – | −42.9% | −0.62% | – | 0.00% | |
| 152 | $28.35 | +1.9% | $3.0B | 20.3% | 9.0 | 6 | – | +12.5% | −25.6% | −25.4% | 6.3% | |
| 153 | $80.84 |
| −2.4% |
| $3.1B |
| 18.9% |
| 12.8 |
| 3 |
| – |
| – |
| – |
| – |
| – |
| 154 | $40.03 | +2.0% | $3.2B | 18.5% | 7.2 | 8 | – | +57.6% | +32.4% | 2.2% | – |
| 155 | $34.25 | −1.0% | $3.2B | 15.6% | 10.5 | 16 | 7.2× | +10.8% | +0.96% | 27.1% | – |
| 156 | $67.50 | +2.1% | $3.2B | 16.9% | 7.8 | 16 | 18.0× | +48.3% | +12.8% | 17.3% | – |
| 157 | $31.22 | +2.9% | $3.2B | 20.3% | 10.6 | 13 | 18.7× | +14.9% | −5.2% | 4.8% | 2.4% |
| 158 | $78.36 | −2.9% | $3.3B | 19.2% | 10.4 | 21 | 11.0× | +34.8% | +4.7% | 13.4% | – |
| 159 | $16.60 | −1.3% | $3.3B | 16.3% | 9.8 | 4 | – | −24.6% | −1.4% | −6.4% | 6.0% |
| 160 | $58.60 | −2.7% | $3.4B | 15.9% | 15.0 | 10 | 24.2× | −0.48% | +17.3% | 7.8% | 1.2% |
| 161 | $69.13 | −0.25% | $3.4B | 22.4% | 11.0 | 1 | – | – | – | – | – |
| 162 | $25.65 | −0.81% | $3.4B | 21.3% | 5.5 | 14 | 25.9× | +45.1% | −10.4% | 10.1% | – |
| 163 | $50.36 | −1.1% | $3.6B | 17.2% | 12.5 | 13 | – | +48.5% | +8.5% | −16.9% | 4.7% |
| 164 | $22.72 | +0.84% | $3.8B | 26.4% | 12.5 | 10 | – | −129% | +121% | −230% | – |
| 165 | $18.35 | −5.8% | $4.0B | 21.3% | 12.6 | 10 | – | – | +23.9% | −2764% | – |
| 166 | $148.38 | −0.87% | $4.3B | 15.8% | 10.5 | 25 | 31.0× | +25.6% | +10.9% | 15.5% | 1.1% |
| 167 | $43.73 | +2.2% | $4.5B | 19.2% | 11.3 | 12 | 36.1× | −84.2% | −2.9% | 2.3% | 5.4% |
| 168 | $18.37 | −1.6% | $4.6B | 15.4% | 9.7 | 11 | 204× | −61.3% | +15.7% | 2.4% | – |
| 169 | dnthDianthus Therapeutics | $82.38 | −0.39% | $4.6B | 16.3% | 8.3 | 7 | – | – | – | – | 0.00% |
|---|
| 170 | $51.42 | −5.2% | $5.0B | 19.3% | 9.6 | 8 | – | – | −64.8% | −3369% | – |
| 171 | $43.90 | −0.63% | $5.3B | 18.7% | 9.3 | 2 | – | – | – | – | – |
| 172 | $151.83 | −1.7% | $5.4B | 19.2% | 5.3 | 9 | 36.9× | −4.8% | −4.3% | 5.2% | 5.8% |
| 173 | $70.70 | +2.3% | $5.4B | 21.3% | 6.2 | 12 | – | −210% | +70.5% | 7.2% | 0.68% |
| 174 | $112.64 | −0.42% | $5.6B | 20.6% | 7.3 | 11 | 30.5× | −50.8% | +5.7% | 4.6% | 1.0% |
| 175 | $16.16 | −1.5% | $6.1B | 20.8% | 9.2 | 11 | 2.3× | – | +10.8% | 42.3% | – |
| 176 | $131.59 | −3.5% | $6.2B | 15.3% | 6.7 | 18 | 15.7× | +42.5% | +29.4% | 35.9% | – |
| 177 | $51.31 | +3.3% | $6.3B | 15.1% | 8.0 | 18 | 9.1× | +34.4% | +4.9% | 18.6% | 3.4% |
| 178 | $92.57 | −0.54% | $6.4B | 15.6% | 14.1 | 5 | – | – | +53.5% | −85.6% | – |
| 179 | $27.68 | −6.7% | $6.5B | 23.5% | 5.3 | 9 | – | −334% | +28.0% | −5.5% | – |
| 180 | $39.57 | −5.0% | $7.0B | 20.6% | 6.8 | 5 | – | −45.6% | +26.1% | −19.9% | – |
| 181 | $6.94 | +3.7% | $7.8B | 26.8% | 6.9 | 4 | – | −14.8% | – | −40.2% | – |
| 182 | $285.93 | −0.93% | $8.0B | 15.0% | 7.2 | 7 | – | – | – | – | – |
| 183 | $61.18 | +5.3% | $9.4B | 20.0% | 15.0 | 10 | 22.3× | +19.7% | +76.1% | 55.2% | – |
| 184 | $40.97 | −4.9% | $15.9B | 16.7% | 6.1 | 4 | – | – | +2257% | −537% | – |
| 185 | $107.94 | −1.9% | $35.9B | 16.0% | 14.2 | 19 | 18.4× | +1.0% | +0.71% | 11.8% | 4.7% |